Cargando…
GTSE1 is possibly involved in the DNA damage repair and cisplatin resistance in osteosarcoma
BACKGROUND: G2 and S phase-expressed-1 (GTSE1) negatively regulates the tumor-suppressive protein p53 and is potentially correlated with chemoresistance of cancer cells. This study aims to explore the effect of GTSE1 on the DNA damage repair and cisplatin (CDDP) resistance in osteosarcoma (OS). MATE...
Autores principales: | Xie, Chaofan, Xiang, Wei, Shen, Huiyong, Shen, Jingnan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8650252/ https://www.ncbi.nlm.nih.gov/pubmed/34876170 http://dx.doi.org/10.1186/s13018-021-02859-8 |
Ejemplares similares
-
GTSE1 expression represses apoptotic signaling and confers cisplatin resistance in gastric cancer cells
por: Subhash, Vinod Vijay, et al.
Publicado: (2015) -
Knockdown GTSE1 enhances radiosensitivity in non–small‐cell lung cancer through DNA damage repair pathway
por: Lei, Xiao, et al.
Publicado: (2020) -
The inhibition of MARK2 suppresses cisplatin resistance of osteosarcoma stem cells by regulating DNA damage and repair
por: Xu, Liang, et al.
Publicado: (2020) -
GTSE1 is involved in breast cancer progression in p53 mutation-dependent manner
por: Lin, Fen, et al.
Publicado: (2019) -
HOXB7 mediates cisplatin resistance in esophageal squamous cell carcinoma through involvement of DNA damage repair
por: Zhou, Ting, et al.
Publicado: (2019)